BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22517003)

  • 41. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.
    Abd El-Maqsoud NM; Abd El-Rehim DM
    Clin Breast Cancer; 2014 Feb; 14(1):e1-9. PubMed ID: 24201161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.
    Strati A; Kasimir-Bauer S; Markou A; Parisi C; Lianidou ES
    Breast Cancer Res; 2013 Mar; 15(2):R20. PubMed ID: 23497487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
    Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
    In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.
    de Albuquerque A; Kubisch I; Breier G; Stamminger G; Fersis N; Eichler A; Kaul S; Stölzel U
    Oncology; 2012; 82(1):3-10. PubMed ID: 22270149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.
    Gires O; Stoecklein NH
    Cell Mol Life Sci; 2014 Nov; 71(22):4393-402. PubMed ID: 25103341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
    Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
    Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
    Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H
    Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
    PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
    Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
    Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.
    Tryfonidis K; Kafousi M; Perraki M; Apostolaki S; Agelaki S; Georgoulias V; Stathopoulos E; Mavroudis D
    Clin Breast Cancer; 2014 Dec; 14(6):442-50. PubMed ID: 24958324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells.
    Zieglschmid V; Hollmann C; Gutierrez B; Krehan A; Kaul S; Böcher O
    Anticancer Res; 2007; 27(4A):1769-76. PubMed ID: 17649771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.
    Nini A; Hoffmann MJ; Lampignano R; Große Siemer R; van Dalum G; Szarvas T; Cotarelo CL; Schulz WA; Niederacher D; Neubauer H; Stoecklein NH; Niegisch G
    Cytometry B Clin Cytom; 2020 Jul; 98(4):355-367. PubMed ID: 32212383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EpCAM: a potential antimetastatic target for gastric cancer.
    Du W; Ji H; Cao S; Wang L; Bai F; Liu J; Fan D
    Dig Dis Sci; 2010 Aug; 55(8):2165-71. PubMed ID: 19941073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
    Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
    Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
    Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
    Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.
    Lampignano R; Schneck H; Neumann M; Fehm T; Neubauer H
    Adv Exp Med Biol; 2017; 994():181-203. PubMed ID: 28560675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.